Mongolia | ClinicalTrials HQ

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Cities	City	Country	Linked trials
Ulaanbaatar	Ulaanbaatar	Mongolia	4

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, multidrug-resistant tuberculosis, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis	Recruiting	Phase 2 / Phase 3	2026-09-02		NCT06441006
Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, disease arising from reactivation of latent virus, gram-positive bacterial infections, latent tuberculosis infection, mycobacterial infectious disease, tuberculosis	Recruiting	Phase 2 / Phase 3	2026-08-18		NCT06568484
A Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis D	Digestive System Diseases, Infections, RNA Virus Infections, hepatitis, hepatitis D virus infection, liver disorder, viral hepatitis, viral infectious disease	Active, not recruiting	Phase 2	2025-12-23		NCT06505928
Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis	Brain Diseases, Metabolic, Digestive System Diseases, Hepatic Insufficiency, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder	Active, not recruiting	Phase 3	2025-09-10		NCT05297448